Microbiome rejuvenation enhances intestinal health and reduces inflammaging in mice
Alterations in composition and function of the intestinal microbiota have been observed in organismal aging across a broad spectrum of animal phyla. Recent findings, which have been derived mostly in simple animal models, have even established a causal relationship between age-related microbial shifts and lifespan, suggesting microbiota-directed interventions as a potential tool to decelerate aging processes. To test whether a life-long microbiome rejuvenation strategy could delay or even prevent aging in mammals, we performed recurrent fecal microbial transfer in mice throughout life. Transfer material was either derived from 8-week-old mice (young microbiome, yMB) or from animals of the same age as the recipients (isochronic microbiome, iMB) as control. Physiological responses were analyzed by rotarod and a grip strength test, intestinal barrier function by FITC gavage and LAL assay, transcriptional responses by single cell RNA sequencing and microbiome function by 16S profiling and metagenomics. Colonization with yMB improved coordination and intestinal permeability compared to iMB. yMB encoded fewer pro-inflammatory factors and altered metabolic pathways favoring oxidative phosphorylation. Ecological interactions among bacteria in yMB were more antagonistic than in iMB hinting at more stable microbiome communities. scRNAseq analysis of intestinal mucosa revealed a salient shift of cellular phenotypes in the yMB group, with markedly increased ATP synthesis and mitochondrial pathways within goblet and enteroendocrine cells but reduced inflammatory signaling in B lymphocytes. Taken together, we demonstrate that life-long, repeated FMT with microbiota material from young mice influences age-related processes including motor coordination, intestinal permeability and immune cell phenotypes.